Adverse events during testosterone replacement therapy in 95 young hypogonadal thalassemic men

Vincenzo de Sanctis*, Ashraf T. Soliman, Shahina Daar, Salvatore di Maio

*المؤلف المقابل لهذا العمل

نتاج البحث: المساهمة في مجلةمراجعة النظراء

7 اقتباسات (Scopus)

ملخص

Background: Hormonal treatment of hypogonadism in thalassaemia major (TM) is a complex issue due to the co-existence of other contributing factors such as severity of iron overload, associated chronic liver disease and other endocrine complications. Objectives: Data about adverse events (AEs) of testosterone replacement therapy (TRT) in hypogonadal males with TM is scarce.We report the adverse events registered during TRT in 95 young patients with TM. Results: These AEs included gynecomastia, documented in 41/95 (43.1%) TM patients of mild to moderate severity (90%). Persistent pain in the injection site and local reactions to testosterone (T) skin patch occurred in a third of patients. Priapism was reported in 2 patients on treatment with intramuscular T enanthate. In both patients, substitution with T gel was successful, and no recurrence during the following 24 months was observed. Conclusions: Clinicians should exercise caution when considering TRT for hypogonadal men with TM.

اللغة الأصليةEnglish
الصفحات (من إلى)228-232
عدد الصفحات5
دوريةActa Biomedica
مستوى الصوت90
رقم الإصدار2
المعرِّفات الرقمية للأشياء
حالة النشرPublished - مايو 23 2019
منشور خارجيًانعم

ASJC Scopus subject areas

  • ???subjectarea.asjc.2700???

بصمة

أدرس بدقة موضوعات البحث “Adverse events during testosterone replacement therapy in 95 young hypogonadal thalassemic men'. فهما يشكلان معًا بصمة فريدة.

قم بذكر هذا